Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema.

Int Ophthalmol · 2023 · PMC10400663 · PMID 37083870

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

fell just short of statistical significancep = 0.06so close (0.05 < p ≤ 0.1)

[ 20 ] also found that the difference between the initial and posttreatment mean macular thickness in DME fell just short of statistical significance ( p = 0.06) after applying topical bromfenac only.

also in 24 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.